WestEnd Advisors’s Organon & Co OGN Stock Holding History

WestEnd Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$69	–	306
2023 Q3	$69	Buy	+4	New	+$83	﹤0.01%	284
2023 Q1	–	Sell	-3	Closed	-$81	–	295
2022 Q4	$84	Hold	3	–	–	﹤0.01%	284
2022 Q3	$0	Hold	3	–	–	﹤0.01%	279
2022 Q2	$101	Buy	+3	New	+$105	﹤0.01%	268
2022 Q1	–	Sell	-2	Closed	-$68	–	320
2021 Q4	$60	Buy	+2	New	+$65	﹤0.01%	374
2021 Q3	–	Hold	0	–	–	–	364
2021 Q2	–	Hold	0	–	–	–	365

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

WestEnd Advisors's OGN Position: Q4 2023 in Review

WestEnd Advisors sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 4 shares — an estimated $69 sold.

WestEnd Advisors first reported a position in OGN in Q4 2021 and held it in 5 quarters. The position peaked at $101 in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

WestEnd Advisors reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
WestEnd Advisors sold 4 Organon & Co shares in Q4 2023, an estimated $69.
WestEnd Advisors first reported a position in Organon & Co in Q4 2021 and held it in 5 quarters.
WestEnd Advisors's Organon & Co position peaked at $101 in Q2 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on WestEnd Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.